Overall, the global hyperbaric oxygen therapy devices market is fragmented in nature on account of the presence of numerous small scale vendors. However, the global market is dominated by a handful of prominent players that have their operations worldwide.Some of the key players operating in the hyperbaric oxygen therapy devices market are Sechrist Industries, Inc., Perry Baromedical, and Environmental Tectonics Corporation (ETC), HAUX-LIFE-SUPPORT GmbH, IHC Hytech B.V., Oxyheal International and Fink Engineering.
The global hyperbaric oxygen therapy devices market will likely expand at a CAGR of 7.4% between 2017 and 2025 to become worth US$284.8 mn by 2025 from US$ 150.0 mn in 2016.Various strategies are leveraged by success-hungry players in the global hyperbaric oxygen therapy devices market. One of them is the thrust on research and development to come up with new or better products. Their focus is on building cost-effective medical devices that would see greater uptake. Strategic partnerships are also being undertaken by them to diversify product portfolios and gain greater share. Further, companies are shifting their gaze to developing countries that offer lucrative opportunities.
Depending upon the type of products, the global hyperbaric oxygen therapy devices market can be bifurcated into monoplace HBOT devices and multiplace HBOT devices. Among them, the monoplace HBOT devices accounted for about 60.1% share in the global market in 2016. Some of the factors leading to its swift uptake are technological progress that bring about smoother and quicker healing of wounds, lower price compared to multiplace chambers, helpful regulatory policies in North America, and patients’ hygiene.
Request A Sample-
Geographically, the key segments of the global hyperbaric oxygen therapy devices market are North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Of them, North America currently leads the market. In 2016, its leading share came to over 32.1%. The market is primarily driven by the U.S. on account of its easy reimbursement policies.